ORBIMED ADVISORS LLC: BIOA position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on BIOA, newest first. How the timeline and the estimate are built.
ORBIMED ADVISORS LLC held 752,153 BIOA shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 752,153 sharesChange vs previous 13F +40,342 shares
0.35% of the 13F portfolio, value $18,435,270.
13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 711,811 sharesChange vs previous 13F -79,090 shares
0.27% of the 13F portfolio, value $12,449,574.
13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 790,901 sharesChange vs previous 13F 0 shares
0.21% of the 13F portfolio, value $10,463,620.
13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 790,901 sharesChange vs previous 13F -131,058 shares
0.11% of the 13F portfolio, value $4,650,498.
13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 921,959 sharesChange vs previous 13F 0 shares
0.1% of the 13F portfolio, value $3,807,691.
13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 921,959 sharesChange vs previous 13F 0 shares
0.08% of the 13F portfolio, value $3,466,566.
13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 921,959 sharesChange vs previous 13F -501,511 shares
0.11% of the 13F portfolio, value $5,338,143.
13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 1,423,470 sharesChange vs previous 13F not available
0.54% of the 13F portfolio, value $29,608,176.
13F-HR 0001172661-24-005167 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).